Document is current
Any future updates will be listed below
-
Authors
Niazi, Sarfaraz K.
- License Information
-
More Information
Article History
Received: 26 June 2025
Accepted: 5 February 2026
First Online: 28 February 2026
Declarations
:
: Not applicable.
: Not applicable.
: The author is an advisor to the US FDA, EMA, and MHRA; the US Senate; the White House; and several heads of state; he is also a developer of novel biological drugs. He holds equity interests in RNA Therapeutics, DEI Biopharma, and Abyolo.
